Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Cancer Articles A-Z

Kidney Cancer Surgery - Leaving the Hospital After ERCP (With Dilation and Stent Placement) -- Information for Diabetic Patients

This page contains links to eMedTV Cancer Articles containing information on subjects from Kidney Cancer Surgery to Leaving the Hospital After ERCP (With Dilation and Stent Placement) -- Information for Diabetic Patients. The information is organized alphabetically; the "Favorite Articles" contains the top articles on this page. Links in the box will take you directly to the articles; those same links are available with a short description further down the page.
Favorite Articles
Descriptions of Articles
  • Kidney Cancer Surgery
    While there are several treatment options for kidney cancer, surgery is one of the most common. This eMedTV article describes the three basic forms of surgery: partial nephrectomy, simple nephrectomy, and radical nephrectomy.
  • Kidney Cancer Survival Rates
    Kidney cancer survival rates refer to the percentage of people who survive the disease for a certain time. This eMedTV segment provides overall survival rates for people with kidney cancer, as well as survival rates based on stage of the disease.
  • Kidney Cancer Symptoms
    For people with kidney cancer, symptoms may include blood in the urine, pain in the side, and fever. This eMedTV Web page discusses a number of possible symptoms, including a lump or mass in the side or the abdomen, weight loss, and fatigue.
  • Kidney Cancer Treatment
    As this eMedTV page explains, treating kidney cancer may involve surgery, arterial embolization, or other treatments. This article takes an in-depth look at treating this disease, including information about second opinions, nutrition, and follow-up care.
  • Kidney Cancer Treatment by Stage
    Kidney cancer treatment often varies based on the stage (or extent) of the disease. This eMedTV article breaks down kidney cancer treatment by stage, which may involve options such as surgery, chemotherapy, radiotherapy, and arterial embolization.
  • Kidney Cancer Types
    As this eMedTV article explains, there are several types of kidney cancer. A few of these kidney cancer types include renal cell carcinoma, transitional cell carcinoma, and Wilms' tumor. This Web page discusses these types of kidney cancer.
  • Kyprolis
    Kyprolis is a drug prescribed to treat multiple myeloma after at least two other medications have failed. This eMedTV Web selection explores this prescription drug in more detail, with information on how it works, potential side effects, and other topics.
  • Kyprolis and Breastfeeding
    This eMedTV Web page discusses why it may not be safe for women to use Kyprolis (carfilzomib) while breastfeeding. This page explains if any research has been done on this topic and whether it is known if the drug passes through breast milk.
  • Kyprolis and Pregnancy
    The FDA has classified Kyprolis (carfilzomib) as a pregnancy Category D drug. This eMedTV resource looks at the reasons why this drug may not be safe for pregnant women. It also discusses the animal research that has been done on this topic.
  • Kyprolis Chemotherapy Information
    Before starting chemotherapy with Kyprolis, your doctor will need information on your medical history. This eMedTV page examines other important details to discuss with your doctor. It also explains how the drug is given, how it works, and side effects.
  • Kyprolis Dosage
    As explained in this eMedTV segment, Kyprolis is given as an intravenous injection once a day for two days in a row every seven days. This article explains how your individual dose of Kyprolis is determined and discusses how long treatment lasts.
  • Kyprolis Drug Interactions
    As this eMedTV article explains, your doctor will need an up-to-date list of any medications or supplements you are taking before prescribing Kyprolis. This page explains how clozapine, pimozide, and other products could cause Kyprolis drug interactions.
  • Kyprolis Overdose
    As this part of the eMedTV Web library explains, overdosing on Kyprolis (carfilzomib) may cause problems like vomiting, diarrhea, and bleeding problems. Other potential overdose symptoms and treatment options are described in this article.
  • Kyprolis Side Effects
    Most people who receive Kyprolis will develop some type of side effect. This eMedTV resource takes a closer look at some of the common reactions to Kyprolis, as well as the problems that are more serious and require urgent medical treatment.
  • Kyprolis Uses
    As this eMedTV article explains, if you have multiple myeloma that has gotten worse after at least two other treatments, you may receive Kyprolis. This page examines uses for Kyprolis, including details on how it works and whether it is safe for children.
  • Kyprolis Warnings and Precautions
    Kyprolis may lead to heart problems, dangerous bleeding, or other serious complications. This eMedTV Web page focuses on why this medicine may not be safe for some people. A list of important Kyprolis warnings and precautions is also included.
  • Kytril
    Kytril is a drug that is prescribed to prevent nausea and vomiting caused by chemotherapy or radiation. This eMedTV resource explains how Kytril works and offers a more in-depth look at dosing information, effects, and possible side effects.
  • Kytril and Breastfeeding
    It is not known whether Kytril passes through breast milk in breastfeeding women. This eMedTV article offers more information on Kytril and breastfeeding, and explains why no studies have been conducted on whether Kytril passes through breast milk.
  • Kytril and Hair Loss
    Up to 3 percent of people have reported hair loss while taking Kytril. This section of the eMedTV library explores the link between Kytril and hair loss in more detail and explains what your doctor may recommend if hair loss occurs during treatment.
  • Kytril and Pregnancy
    It is generally considered safe for pregnant women to take Kytril for a short amount of time. As this eMedTV page explains, studies on Kytril and pregnancy show that the drug did not cause any problems when it was given to pregnant rats.
  • Kytril Dosage
    To prevent nausea and vomiting due to radiation, the recommended Kytril dosage is 2 mg. This eMedTV article also provides Kytril dosage recommendations for chemotherapy and offers tips on when and how to take the drug.
  • Kytril Drug Information
    Kytril is often prescribed to prevent nausea and vomiting due to chemotherapy and radiation. This eMedTV segment features more information on Kytril, such as dosing guidelines for the drug and safety warnings to keep in mind.
  • Kytril Drug Interactions
    If phenobarbital or ketoconazole is taken together with Kytril, drug interactions may occur. This page on the eMedTV Web site offers a more detailed explanation of what may happen when these and other medications interact with Kytril.
  • Kytril Overdose
    A slight headache has been reported as a possible symptom of Kytril overdose. As this eMedTV resource explains, however, since doctors generally give only a few tablets of Kytril to patients, an overdose with the drug is unlikely.
  • Kytril Side Effects
    Insomnia, diarrhea, and abdominal pain are some of the most commonly reported Kytril side effects. This eMedTV Web page lists other possible side effects of Kytril and describes potentially serious side effects that require medical attention.
  • Kytril Uses
    Kytril is used for preventing nausea and vomiting caused by radiation or chemotherapy. This part of the eMedTV archives discusses Kytril uses in more detail, including information on whether it is approved for use in children.
  • Kytril Warnings and Precautions
    Your body may not metabolize Kytril as well as it should if you have liver disease. This eMedTV Web page provides other important Kytril warnings and precautions, and includes information on who should not take the medication.
  • Laparascopically Assisted Vaginal Hysterectomy (LAVH) Presentation -- Summary
    This multimedia clip provides a summary of hysterectomies.
  • Laparascopically Assisted Vaginal Hysterectomy -- Major Complications
    This clip introduces major complications with vaginal hysterectomy and possible outcomes.
  • Laparoscopically Assisted Vaginal Hysterectomy -- The Procedure
    This video guides you through the process of a laparoscopic-assisted vaginal hysterectomy.
  • Lapatinib
    Lapatinib is a drug that is used for treating metastatic breast cancer. This eMedTV article explains how the medication works, offers dosing information, and lists possible side effects.
  • Lapatinib Dosing
    The usual recommended dose of lapatinib for treating breast cancer is 1250 mg or 1500 mg, taken once daily. This eMedTV page offers more detailed dosing guidelines, including a list of precautions and tips for taking the medication.
  • Lapatinib for Breast Cancer
    This eMedTV resource explains when breast cancer may be treated with lapatinib. It also describes briefly how this medication works and offers a link to more detailed information on this topic.
  • LAVH Results for Abnormal Uterine Bleeding
    This clip offers information on abnormal uterine bleeding after the procedure.
  • LAVH Results for Endometroisis
    This clip talks about the expected results for patients with endometriosis.
  • LAVH Results for Fibroids
    This clip discusses the effects of a hysterectomy on fibroids.
  • LAVH Results for Precancerous and Cancerous Conditions
    This clip discusses the possible outcomes of a hysterectomy for pre-cancerous conditions or cancerous growths.
  • LAVH Results for Prolapsed Structures
    This clip explains how a hysterectomy will affect prolapsed structures.
  • LAVH Risks -- Abdominal Adhesions
    This video clip covers abdominal adhesions and how they are formed.
  • LAVH Risks -- Air Insufflation Injuries
    This video clip describes air sufflation injuries that can occur with a laparoscopy.
  • LAVH Risks -- Allergic Reaction to Medication
    This video explains why allergic reactions to medicines occur and how likely they are.
  • LAVH Risks -- Bladder and Urinary Tract Injury
    This video discusses possible bladder and urinary tract injuries.
  • LAVH Risks -- Bleeding and Blood Vessel Damage
    This clip talks about bleeding and blood vessel damage during surgery.
  • LAVH Risks -- Blood Clots
    This video clip deals with blood clots after surgery.
  • LAVH Risks -- Complications From the Incisions
    This video clip provides an overview of the complications that can occur with laparoscopy.
  • LAVH Risks -- Conversion From Laparoscopic to Abdominal Surgery
    This clip explains why an open abdominal surgery may be needed instead of laparoscopy.
  • LAVH Risks -- Delayed Bowel Function, or Ileus
    This video file explains how, why, and when an ileus (delayed bowel function) may occur.
  • LAVH Risks -- Fistulas
    This video clip offers a brief overview of fistulas.
  • LAVH Risks -- Infection
    This video clip talks about the possibility of getting an infection after your surgery.
  • LAVH Risks -- Intestine or Bowel Injury
    This video describes what bowel or intestinal injuries can occur and how they are treated.
  • LAVH Risks -- Loss of Life
    This clip offers information on the possibility of loss of life during surgery .
  • LAVH Risks -- Need for Major Abdominal Surgery
    This clip discusses the possibility of needing major abdominal surgery during your planned surgery.
  • LAVH Risks -- Nerve Damage
    This video clip talks about nerve damage during surgery.
  • LAVH Risks -- Organ Damage
    This video clip explains how organs are sometimes damaged during surgery.
  • LAVH Risks -- Urinary Incontinence
    This video summary offers an overview on urinary incontinence.
  • LAVH Risks -- Urinary Tract Infection
    This video clip discusses urinary tract infection.
  • LAVH Risks -- Wound Breakdown
    This video explains why some wounds may not heal well after surgery.
  • LAVH Risks As a Diabetic
    People with diabetes have special risks during this procedure, which this video clip describes.
  • LAVH-- What Happens Right Before Your Procedure
    This video segment explains what will happen right before your procedure.
  • Lazanda
    Available by prescription only, Lazanda is a drug that helps treat breakthrough cancer pain. This eMedTV Web selection explains how this narcotic nasal spray works, offers some general dosing information, describes potential side effects, and more.
  • Lazanda Abuse
    This eMedTV segment explains that Lazanda (fentanyl nasal spray) is a narcotic that is often abused. This article outlines the potentially serious effects of Lazanda abuse, such as breathing problems, extreme drowsiness, and a coma.
  • Lazanda and Breastfeeding
    As this eMedTV article explains, women are not advised to use Lazanda (fentanyl nasal spray) while breastfeeding. This article further explores this topic, including a description of the potential problems this drug may cause in a nursing infant.
  • Lazanda and Pregnancy
    As this eMedTV page explains, pregnant women may not be able to safely use Lazanda (fentanyl nasal spray). This page discusses the results of animal studies and lists problems that may occur in a newborn if the mother uses Lazanda during pregnancy.
  • Lazanda Dosage
    As this eMedTV segment explains, the standard starting dose of Lazanda is 100 mcg no more often than every two hours, for a maximum of four doses a day. This page describes the factors that may affect your dosage and lists some general dosing tips.
  • Lazanda Drug Interactions
    Serious interactions can occur if you use Lazanda with drugs such as alcohol or MAOIs. This eMedTV segment offers details on how to reduce your risk of the complications these and other reactions may cause, such as confusion and breathing problems.
  • Lazanda Medication Information
    If you have breakthrough cancer pain, you may benefit from Lazanda. This eMedTV article offers some general information on Lazanda, including how this medication works, dosing guidelines, and possible side effects. A link to more details is also included.
  • Lazanda Overdose
    This eMedTV page describes the potentially life-threatening problems that can result from an overdose of Lazanda (fentanyl nasal spray), such as difficulty breathing, coma, or death. This page lists other overdose symptoms and describes treatment options.
  • Lazanda Side Effects
    Nausea, vomiting, and constipation are some of the most commonly reported side effects of Lazanda. This eMedTV page offers a detailed description of possible side effects, including statistics on how often these problems occurred during clinical trials.
  • Lazanda Storage and Disposal
    As this eMedTV Web page discusses, keep Lazanda (fentanyl nasal spray) in a safe place and dispose of any remaining liquid in the special pouch that comes with the drug. This page further explains proper Lazanda disposal and storage methods.
  • Lazanda Uses
    Adults who have breakthrough cancer pain may benefit from Lazanda. This article from the eMedTV Web site takes a closer look at what Lazanda is used for, how it works to relieve cancer pain, and when a doctor may prescribe it for unapproved uses.
  • Lazanda Warnings and Precautions
    As this eMedTV page discusses, people with certain conditions, such as COPD or liver disease, may need to use extra caution with Lazanda. Other important warnings and precautions are described in this article, including who should not use this drug.
  • Leaving the Hospital (Laparascopically Assisted Vaginal Hysterectomy)
    This video explains what to expect when leaving the hospital after your procedure.
  • Leaving the Hospital - Diabetic (LAVH)
    This video clip features information for diabetic patients who are leaving the hospital.
  • Leaving the Hospital After ERCP (With Dilation and Stent Placement)
    This multimedia clip discusses possible discharge instructions following an ERCP.
  • Leaving the Hospital After ERCP (With Dilation and Stent Placement) -- Information for Diabetic Patients
    This video explains what diabetic patients can expect after leaving the hospital.
  • Letrazole
    Postmenopausal women with certain forms of breast cancer are often prescribed letrozole as a treatment. This eMedTV segment takes a brief look at the drug and offers a link to more in-depth information. Letrazole is a common misspelling of letrozole.
  • Letrozol
    Letrozole is approved for postmenopausal women with certain forms of breast cancer. This page of the eMedTV archives offers a brief description of the drug, including dosing information and side effects. Letrozol is a common misspelling of letrozole.
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.